Stay updated on LAP of Mepolizumab for MEA115921 Participants Clinical Trial
Sign up to get notified when there's something new on the LAP of Mepolizumab for MEA115921 Participants Clinical Trial page.

Latest updates to the LAP of Mepolizumab for MEA115921 Participants Clinical Trial page
- CheckyesterdayChange DetectedThe page now shows Revision: v3.5.2, replacing Revision: v3.5.0.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedRevision: v3.5.0 added; Revision: v3.4.3 removed.SummaryDifference0.0%

- Check37 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check66 days agoChange DetectedAdded Revision: v3.4.2; deleted the funding-lapse notice and Revision: v3.4.1. No study content changes are present.SummaryDifference0.3%

- Check73 days agoChange DetectedNotice of government funding lapse and an updated Revision: v3.4.1 were added; no changes to core study content or data are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check80 days agoChange DetectedAdded a glossary display, introduced a QC status field (Last Update Submitted that Met QC Criteria), and updated the page revision to v3.4.0. Removed the older No FEAR Act data label and the previous revision text (v3.3.4).SummaryDifference0.2%

Stay in the know with updates to LAP of Mepolizumab for MEA115921 Participants Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LAP of Mepolizumab for MEA115921 Participants Clinical Trial page.